TRANSPLANT IMMUNOLOGY
BROWSE TOPICS
NEWS
Explore core concepts across
transplant immunology.
What’s happening in the
transplant immunology world.
Transplant Immunology
×
TRANSPLANT IMMUNOLOGY
Browse topics
1Basic and Mechanistic Transplantation Immunology
- 1.1Foundations and Historical Development of Transplantation Immunology
- 1.2Transplantation Antigens and Biological Basis of Graft Compatibility
- 1.3Antigen Processing, Presentation and Allorecognition
- 1.4Innate Immunity in Transplantation
- 1.5Ischaemia-Reperfusion Injury and Early Graft Inflammation
- 1.6T-Cell Immunity and Cellular Alloimmune Responses
- 1.7B-Cell Immunity and Humoral Alloimmunity
- 1.8Antibody-Mediated Immune Injury and Effector Mechanisms
- 1.9Complement, Coagulation and Thromboinflammation
- 1.10Mechanisms and Classification of Allograft Rejection
- 1.11Graft Pathology and Clinicopathological Correlation
- 1.12Transplant Tolerance and Immune Regulation
- 1.13Graft Tissue Immunobiology and Immune-Cell Trafficking
- 1.14Organ-Specific Transplantation Immunobiology
- 1.15Allogeneic HCT Immunobiology
- 1.16Emerging and Systems-Level Transplantation Immunology
2Histocompatibility Antigens, Immunogenetics and Alloantibody Biology
- 2.1Fundamentals of Human Immunogenetics
- 2.2Organisation and Genetics of the MHC
- 2.3HLA Molecular Structure and Function
- 2.4HLA-A, HLA-B and HLA-C
- 2.5HLA Class II Genetics
- 2.6HLA Polymorphism and Structural Immunogenicity
- 2.7Minor Histocompatibility Antigens
- 2.8Non-HLA Antigen Systems
- 2.9ABO and Other Blood-Group Systems
- 2.10HNA and HPA Systems
- 2.11KIR and NK-Cell Immunogenetics
- 2.12Other Immunogenetic Modifiers
- 2.13Alloantibody Biology
- 2.14HLA Antibodies and Alloimmune Specificity
- 2.15Emerging Immunogenetics and Computational Approaches
3Clinical Histocompatibility and Immunological Risk Assessment
- 3.1Foundations of Clinical Histocompatibility
- 3.2HLA Typing and Donor–Recipient Compatibility Assessment
- 3.3HLA Antibody Screening and Characterisation
- 3.4Donor-Specific Antibody Assessment
- 3.5Histocompatibility Crossmatching
- 3.6Immunological Risk Assessment in Solid-Organ Transplantation
- 3.7Immunological Risk Assessment in Allogeneic HCT
- 3.8ABO and Non-HLA Compatibility Assessment
- 3.9Desensitisation and Management of Immunological Risk
- 3.10Post-Transplant Immunological Monitoring
- 3.11Immunological Assessment of Special Clinical Scenarios
- 3.12Clinical Histocompatibility Consultation and Decision Support
4Clinical Transplantation
- 4.1Principles of Clinical Organ Transplantation
- 4.2Kidney Transplantation
- 4.3Liver Transplantation
- 4.4Heart Transplantation
- 4.5Lung Transplantation
- 4.6Pancreas and Islet Transplantation
- 4.7Intestinal and Multivisceral Transplantation
- 4.8Vascularised Composite Allotransplantation
- 4.9Immunosuppression in Clinical Transplantation
- 4.10Treatment of Allograft Rejection
- 4.11Infection and Infectious Complications
- 4.12Non-Immunological and Systemic Complications
- 4.13Long-Term Transplant Care and Outcomes
5Laboratory Technologies
- 5.1Foundations of the Histocompatibility Laboratory
- 5.2Serological HLA Typing
- 5.3Molecular HLA Typing
- 5.4HLA Antibody Detection and Identification
- 5.5Crossmatch Technologies
- 5.6Cellular Immunology and Functional Assays
- 5.7HLA and Immunogenetic Testing Beyond Classical HLA
- 5.8Chimerism and Engraftment Monitoring
- 5.9ABO and Transfusion-Related Laboratory Testing
- 5.10Emerging and Advanced Laboratory Technologies
- 5.11Laboratory Method Validation and Analytical Performance
- 5.12Laboratory Informatics and Data Interpretation
6Laboratory Directorship
- 6.1Foundations of Histocompatibility Laboratory Directorship
- 6.2Regulatory Framework and Laboratory Accreditation
- 6.3Quality Management Systems
- 6.4Proficiency Testing and External Quality Assessment
- 6.5Laboratory Method Validation and Test-System Oversight
- 6.6Laboratory Operations and Resource Management
- 6.7Personnel Management and Competency Assessment
- 6.8Laboratory Safety and Risk Management
- 6.9Pre-Analytical and Post-Analytical Oversight
- 6.10Clinical Service Agreements and Consultation Governance
- 6.11Laboratory Informatics, Data Governance and Cybersecurity
- 6.12Financial Management and Strategic Leadership
- 6.13Inspection, Accreditation and Laboratory Readiness
7Clinical Consultation and Professional Development
- 7.1Foundations of Clinical Histocompatibility Consultation
- 7.2Interpretation of HLA Typing and Compatibility Results
- 7.3Interpretation of HLA Antibody Results
- 7.4Clinical Interpretation of Crossmatches and Virtual Crossmatches
- 7.5Donor Selection and Transplant Compatibility Consultation
- 7.6Clinical Consultation in Highly Sensitised Patients
- 7.7Post-Transplant Consultation and Alloimmune Monitoring
- 7.8Clinical Consultation in Allogeneic HCT
- 7.9Consultation in Transfusion and Other Immunogenetic Conditions
- 7.10Complex Case Interpretation and Clinical Problem-Solving
- 7.11Professional Practice, Ethics and Communication
- 7.12Professional Development and Certification
- 7.13Clinical Research, Evidence-Based Practice and Future Directions
×
TRANSPLANT IMMUNOLOGY
News
News and updates from the transplant immunology world will appear here.
×
ABOUT
Transplant Immunology
An educational resource for trainees and researchers exploring transplant immunology.